SWOG clinical trial number
SWOG-8300

Treatment of Limited Non-Small Cell Lung Cancer: Radiation Versus Radiation Plus Chemotherapy (FOMi/CAP)

Closed
Phase
Published
Abbreviated Title
Treatment of Limited Non-Small Cell Lung Cancer: Radiation Versus Radiation Plus Chemotherapy (FOMi/CAP)
Activated
07/20/1984
Closed
03/01/1988

Research committees

Lung Cancer

Publication Information Expand/Collapse

2005

Southwest Oncology Group: Two decades of experience in non-small cell lung cancer

AT Turrisi;J Crowley;K Albain;L Gaspar;D Gandara Seminars in Oncology 32(2Suppl3):S119-S121

PMid: PMID16015548

2002

Factorial design considerations

S Green;PY Liu;J O'Sullivan Journal of Clinical Oncology 20(16):3424-3430

1998

A randomized trial of chemotherapy and Radiotherapy for stage III non-small cell lung cancer.

TP Miller;JJ Crowley;JG Mira;JG Schwartz;L Hutchins;L Baker;R Natale;EM Chase;RB Livingston Cancer Therapeutics 1(4):229-236

Other Clinical Trials

SWOG Clinical Trial Number
S2302

PRAGMATICA - LUNG: A PROSPECTIVE RANDOMIZED STUDY OF RAMUCIRUMAB (LY3009806; NSC 749128) PLUS PEMBROLIZUMAB (MK-3475; NSC 776864) VERSUS STANDARD OF CARE FOR PARTICIPANTS PREVIOUSLY TREATED WITH IMMUNOTHERAPY FOR STAGE IV OR RECURRENT NON-SMALL CELL LUNG CANCER
Research Committee(s)
Lung Cancer
Activated
03/06/2023
Accrual
64%
Open
Phase
SWOG Clinical Trial Number
A082002

A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
12/21/2021
Open
Phase
SWOG Clinical Trial Number
CTSU/NRG-LU007

RAndomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Research Committee(s)
Lung Cancer
Activated
08/17/2020
Open